高级检索

    归芪白术方调控let-7a-5p/MDM2/p53轴促进胃癌细胞凋亡和周期阻滞的机制研究

    Mechanism Study of Guiqi Baizhu Formula Regulating the let-7a-5p/MDM2/p53 Axis to Promote Apoptosis and Cell Cycle Arrest in Gastric Cancer Cells

      摘要
    • 摘要:
      目的 探讨归芪白术方调控let-7a-5p/MDM2/p53轴促进胃癌细胞凋亡和周期阻滞的机制。
      方法 网络药理学预测归芪白术方治疗胃癌的活性成分及作用靶点；筛选出let-7a-5p表达水平最低的人胃癌HGC-27细胞，分别在24、48、72 h以不同浓度梯度的归芪白术方冻干粉对其进行干预；CCK-8法检测归芪白术方对HGC-27细胞增殖能力的影响；流式细胞术检测归芪白术方对HGC-27细胞周期和凋亡率的影响；划痕试验检测归芪白术方对HGC-27细胞迁移能力的影响；实时荧光定量聚合酶链式反应(real-time fluorescent quantitative polymerase chain reaction，qRT-PCR)和Western blotting检测归芪白术方对HGC-27细胞中MDM2、p53、Cyclin D1、c-Myc、Bcl-2、Bax的蛋白及mRNA表达水平的影响，以及对let-7a-5p miRNA表达水平的影响。
      结果 网络药理学结果显示，归芪白术方药物有效成分160个，对应靶点872个，胃癌相关基因1656个，得到药物疾病共同靶点245个；药物疾病共同靶点与let-7a-5p下游靶基因交集靶点共37个。CCK8法检测结果显示，归芪白术方在各时段以浓度依赖性方式对HGC-27细胞具有抑制作用；流式细胞术检测结果显示，归芪白术方促进HGC-27细胞周期阻滞和凋亡；细胞划痕试验结果显示，归芪白术方能够抑制HGC-27细胞迁移；qRT-PCR和Western blotting结果显示，归芪白术方能够降低MDM2、CyclinD1、c-Myc、Bcl-2的蛋白和基因表达水平，同时上调let-7a-5p miRNA的表达以及p53、Bax蛋白和基因表达。
      结论 归芪白术方可通过调控let-7a-5p/MDM2/p53轴促进胃癌细胞凋亡和周期阻滞。

       

      Abstract:
      OBJECTIVE To investigate the mechanism by which Guiqi Baizhu formula regulates the let-7a-5p/MDM2/p53 axis to promote apoptosis and cell cycle arrest in gastric cancer cells.
      METHODS Network pharmacology was used to predict the active components and target molecules of Guiqi Baizhu formula in the treatment of gastric cancer; the human gastric cancer HGC-27 cells with the lowest let-7a-5p expression levels were selected, and Guiqi Baizhu formula freeze-dried powder was administered at different concentration gradients at 24, 48, and 72 h; the CCK-8 assay was used to assess the effect of Guiqi Baizhu formula on the proliferation capacity of HGC-27 cells; flow cytometry was used to assess the effects of the formula on the cell cycle and apoptosis rate of HGC-27 cells; a scratch assay was conducted to evaluate the effects of the formula on the migration capacity of HGC-27 cells; real-time fluorescent quantitative polymerase chain reaction(qRT-PCR) and Western blotting were used to assess the effects of the formula on the expression levels of MDM2, p53, Cyclin D1, c-Myc, Bcl-2, and Bax proteins and their mRNA in HGC-27 cells, as well as on the expression level of let-7a-5p miRNA.
      RESULTS Network pharmacology results showed that Guiqi Baizhu formula contained 160 active components, corresponding to 872 target proteins, 1656 gastric cancer-related genes, and 245 common drug-disease targets; there were 37 intersecting targets between the drug-disease common targets and the downstream target genes of let-7a-5p. CCK-8 assay results showed that Guiqi Baizhu formula exhibited concentration-dependent inhibitory effects on HGC-27 cells at various time points; flow cytometry results indicated that Guiqi Baizhu formula promoted cell cycle arrest and apoptosis in HGC-27 cells; scratch assay results demonstrated that Guiqi Baizhu formula inhibited the migratory capacity of HGC-27 cells; qRT-PCR and Western blotting results showed that Guiqi Baizhu formula reduced the protein and gene expression levels of MDM2, Cyclin D1, c-Myc, and Bcl-2, while upregulated the expression of let-7a-5p miRNA as well as the protein and gene expression levels of p53 and Bax.
      CONCLUSION Guiqi Baizhu formula promotes apoptosis and cell cycle arrest in gastric cancer cells by regulating the let-7a-5p/MDM2/p53 axis.

       

      • HTML全文
      • 参考文献(30)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回